Biontech Se Adr (BNTX)

Nov 27, 2025

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035 - GlobeNewswire Inc.

Nov 27, 2025

Nov 22, 2025

Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in BioNTech SE Sponsored ADR $BNTX - Defense World

Nov 22, 2025

Nov 20, 2025

Allworth Financial LP Grows Stake in BioNTech SE Sponsored ADR $BNTX - Defense World

Nov 20, 2025

Nov 19, 2025

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? - Barchart.com

Nov 19, 2025

Nov 18, 2025

Total debt per share of BioNTech SE Sponsored ADR – BER:22UA - TradingView

Nov 18, 2025

Nov 17, 2025

BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ - Finviz

Nov 17, 2025

Nov 16, 2025

BioNTech’s Earnings Call: Progress Amid Challenges - MSN

Nov 16, 2025

Nov 15, 2025

Pfizer Scales Back Major Stake in BioNTech - Ad-hoc-news.de

Nov 15, 2025

Nov 14, 2025

BioNTech Shares Under Pressure as Key Investor Exits - AD HOC NEWS

Nov 14, 2025

Nov 14, 2025

Allianz SE Buys 5,080 Shares of BioNTech SE Sponsored ADR $BNTX - Defense World

Nov 14, 2025

Nov 13, 2025

BioNTech Shares Face Pressure as Pfizer Cuts Stake () - aktiencheck.de

Nov 13, 2025

Nov 13, 2025

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up By Reuters - Investing.com

Nov 13, 2025

Nov 12, 2025

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Nov 12, 2025

Nov 11, 2025

Is BioNTech Stock Building Momentum for a Sustained Recovery? () - aktiencheck.de

Nov 11, 2025

Nov 06, 2025

BioNTech SE (BNTX) Stock Price, Trades & News - GuruFocus

Nov 06, 2025

Nov 05, 2025

BioNTech SE Reports Q3 2025 Financial Results - MSN

Nov 05, 2025

Nov 05, 2025

BioNTech Earnings: Steady Progress in Next-Generation Oncology Pipeline; Guidance Raised - Morningstar

Nov 05, 2025

Nov 03, 2025

BioNTech shares rise as revenue surge offsets earnings miss - Investing.com India

Nov 03, 2025

Nov 01, 2025

BioNTech’s Promising Clinical Study: A New Hope for Advanced Solid Tumors? - MSN

Nov 01, 2025

Nov 01, 2025

BioNTech Faces Critical Earnings Test Amid Divergent Forecasts () - aktiencheck.de

Nov 01, 2025

Oct 31, 2025

BioNTech SE’s Promising Phase 3 Study on NSCLC Treatment: A Potential Game-Changer - TipRanks

Oct 31, 2025

Oct 30, 2025

BioNTech’s BNT327: A Promising New Approach in Breast Cancer Treatment - MSN

Oct 30, 2025

Oct 30, 2025

BioNTech’s BNT116 Study: A New Hope for Advanced Lung Cancer? - MSN

Oct 30, 2025

Oct 30, 2025

BioNTech’s Promising PDAC Study: Market Implications and Progress - MSN

Oct 30, 2025

Oct 29, 2025

BioNTech’s Latest Clinical Study: A New Hope for Advanced Solid Tumors? - TipRanks

Oct 29, 2025

Oct 28, 2025

ETFs Investing in BioNTech SE Sponsored ADR Stocks - TradingView

Oct 28, 2025

Oct 27, 2025

BioNTech’s Latest Study on BNT327: A Potential Game-Changer in Lung Cancer Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Genmab and BioNTech’s Promising Study on Metastatic Colorectal Cancer Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Bristol-Myers Squibb and BioNTech’s New Study: A Potential Game-Changer in Cancer Treatment? - TipRanks

Oct 27, 2025

Oct 27, 2025

Bristol-Myers Squibb and BioNTech Launch New Colorectal Cancer Study - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s Promising Study on BNT113 and Pembrolizumab for Head and Neck Cancer - TipRanks

Oct 27, 2025

Oct 27, 2025

Pfizer and BioNTech’s New Shingles Vaccine Study: A Potential Game Changer - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s Promising Phase 1/2a Trial: A New Hope for Advanced Solid Tumors - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s Promising Phase II Study on MIUC: A Potential Game-Changer? - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s Promising Lung Cancer Study: A Potential Game Changer? - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s BNT326 Study: A New Hope for Advanced Tumor Treatment? - TipRanks

Oct 27, 2025

Oct 27, 2025

Bristol-Myers Squibb and BioNTech SE Launch New Study on Pumitamig for Triple-Negative Breast Cancer - TipRanks

Oct 27, 2025

Oct 27, 2025

Pfizer and BioNTech’s New Study on Variant-Adapted COVID-19 Vaccine for Children: What Investors Need to Know - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech SE’s Promising Phase II Study on Advanced Solid Tumors - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech SE’s New Study on PM8002: A Potential Game-Changer in Colorectal Cancer Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Pfizer and BioNTech’s New Vaccine Study: A Potential Game-Changer for COVID-19 Prevention - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s Latest Clinical Trial: A Potential Game-Changer in Breast Cancer Treatment? - TipRanks

Oct 27, 2025

Oct 27, 2025

BioNTech’s BNT317 Study: A New Hope for Advanced Solid Tumors - TipRanks

Oct 27, 2025

Oct 27, 2025

Pfizer and BioNTech’s Innovative Vaccine Study: A Potential Game-Changer? - TipRanks

Oct 27, 2025

Oct 27, 2025

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings? - Finviz

Oct 27, 2025

Oct 24, 2025

Sector Gamma AS Grows Stake in BioNTech SE Sponsored ADR $BNTX - MarketBeat

Oct 24, 2025

Oct 22, 2025

BioNTech commences exchange offer for CureVac acquisition - Investing.com

Oct 22, 2025

Oct 21, 2025

BioNTech Clears Major Hurdle in CureVac Acquisition Process () - aktiencheck.de

Oct 21, 2025